BioAge Labs BIOA
NASDAQ BIOA
$7.11 -0.03 (-0.42%)
As of: Sep 30, 2026 · 12:45 PM EDT

BioAge Labs, Inc. (BIOA) EBT Margin (2025 - 2026)

Updated

BioAge Labs' EBT Margin was -1056.55% in Q2 2026, down 163.02 percentage points from -893.53% a year earlier and down 257.63 percentage points from the prior quarter.

Analysis

BioAge Labs, Inc. (BIOA) EBT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioAge Labs' EBT Margin was -906.75% through Jun 30, 2026, up 1144.14 percentage points year-over-year; for FY2025, it came in at -893.73%.

  • Per Business Quant data, BIOA's EBT Margin in the three quarters before Q2 2026 was -798.92% (Q1 2026), -835.71% (Q4 2025) and -979.99% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,056.55%
Mar 31, 2026 -798.92%
Dec 31, 2025 -835.71%
Sep 30, 2025 -979.99%
Jun 30, 2025 -893.53%
Mar 31, 2025 -895.04%
API Access

BioAge Labs, Inc. EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=BIOA&period=max&api_key=YOUR_API_KEY